Shigeru Yamagishi

Fujisawa City Hospital

Papers

2

Total Citations

28

H-Index

2

About

Shigeru Yamagishi is a leading colorectal surgeon whose research has significantly advanced the safety and standardization of minimally invasive surgery for rectal cancer. His primary research areas include laparoscopic and robotic colectomy, with a particular focus on optimizing surgical quality and outcomes for locally advanced rectal cancer. Yamagishi’s most impactful contribution is his leadership in the PRODUCT trial (2022), a landmark Japanese multicenter prospective study that rigorously evaluated laparoscopic surgery for locally advanced rectal cancer using the universal quality indicators of circumferential resection margin (CRM) and total mesorectal excision (TME) quality. This work, which has garnered 19 citations, established a validated semi-opened circular specimen processing method, providing crucial evidence to support the oncologic safety of the laparoscopic approach in this challenging patient population. Additionally, his pioneering 2011 case-matched study on solo surgery in laparoscopic colectomy compared robotic and human scopists, demonstrating the feasibility of voice-guided robotic arm assistance. With 9 citations, this work contributed to the evolution of solo surgery techniques, reducing the need for an additional assistant. Yamagishi’s research continues to shape clinical practice guidelines and improve surgical precision in colorectal oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Japanese multicenter prospective study investigating laparoscopic surgery for locally advanced rectal cancer with evaluation of CRM and TME quality (PRODUCT trial)
19 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Fujisawa City Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago